This study found that despite increased activation of AMPK in response to metformin, phosphorylation of p70 S6K in the human breast cancer cell lines MCF-7 (ER-positive) and MDA-MB-231 (ER-negative) was unchanged [50]. The gene discussed is RPS6KB1; the disease is breast carcinoma.